Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer
作者更正:FGFR抑制剂AZD4547治疗内分泌耐药性乳腺癌的IIa期RADICAL试验结果
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-023-35969-4
Coombes, R C; Badman, P D; Lozano-Kuehne, J P; Liu, X; Macpherson, I R; Zubairi, I; Baird, R D; Rosenfeld, N; Garcia-Corbacho, J; Cresti, N; Plummer, R; Armstrong, A; Allerton, R; Landers, D; Nicholas, H; McLellan, L; Lim, A; Mouliere, F; Pardo, O E; Ferguson, V; Seckl, M J